State of Wisconsin Investment Board Has $77.05 Million Holdings in Danaher Corporation $DHR

State of Wisconsin Investment Board cut its position in Danaher Corporation (NYSE:DHR) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 336,576 shares of the conglomerate’s stock after selling 5,599 shares during the quarter. State of Wisconsin Investment Board’s holdings in Danaher were worth $77,049,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. JPL Wealth Management LLC acquired a new stake in Danaher in the 3rd quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher in the 4th quarter worth $26,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the 3rd quarter worth $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter worth $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on DHR. Argus decreased their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Guggenheim decreased their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Jefferies Financial Group restated a “buy” rating and issued a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Price Performance

NYSE:DHR opened at $181.57 on Wednesday. The company has a 50-day moving average of $180.54 and a 200-day moving average of $203.94. The company has a market capitalization of $128.51 billion, a price-to-earnings ratio of 35.12, a PEG ratio of 2.31 and a beta of 0.81. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm earned $1.88 EPS. As a group, equities research analysts anticipate that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.